149 results on '"Chahin, Nizar"'
Search Results
2. Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Immune‐Mediated Necrotizing Myopathy.
3. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
4. Association between Patient Characteristics and Serum Neurofilament Light Chain Level in Patients with Transthyretin-Related Amyloid Cardiomyopathy
5. Relationship Between Myocardial Amyloid Load Measured by 124I-evuzamitide and Prognostic Staging Systems in Transthyretin Amyloid Cardiomyopathy
6. Neurosarcoidosis manifesting as focal sacral inflammatory radiculopathy
7. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
8. CIDP mimics: a case series
9. Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatment
10. Diagnosis of paraproteinemic neuropathy: Room for improvement
11. Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell Therapy
12. Screening for genetic mutations in patients with neuropathy without definite etiology is useful
13. Bright tongue sign in patients with late-onset Pompe disease
14. Nusinersen in adult patients with spinal muscular atrophy: Observations from a single center
15. Diagnostic utility of exome sequencing in the evaluation of neuromuscular disorders
16. Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy
17. Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy
18. Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy – incidental or related?
19. Clinical Reasoning: A 14-year-old boy with fatigue and episodic worsening of weakness
20. Unusual cases of Anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy
21. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
22. Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine
23. A rare case of congenital myopathy with excess muscle spindles: expanding the clinical spectrum of HRAS-associated neuromuscular disease
24. LATE-ONSET BECKER MUSCULAR DYSTROPHY: REFINING THE CLINICAL FEATURES AND ELECTROPHYSIOLOGICAL FINDINGS
25. Occurrence of Anti-Hu and Lambert-Eaton Myasthenic Syndromes in a patient with small cell lung cancer: 21
26. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
27. CIDP mimics: a case series
28. Author Response: Nusinersen in Adult Patients With Spinal Muscular Atrophy: Observations From a Single Center
29. A patient with mutation in the SCN4A p.M1592v presenting with fixed weakness, rhabdomyolysis, and episodic worsening of weakness
30. Neuromuscular Diseases and the Heart
31. Contributors
32. Unwarranted, long term, alglucosidase alfa enzyme replacement therapy in two non-Pompe disease patients
33. Reader response: Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes
34. IVIG Refractory CIDP: Clinical Characteristics, Antibodies, and Response to Alternative Treatment (2504)
35. HIV LUMBOSACRAL RADICULOPLEXUS NEUROPATHY MIMICKING LYMPHOMA: DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME (DILS) RESTRICTED TO NERVE?
36. SERUM CREATINE KINASE LEVELS IN SPINOBULBAR MUSCULAR ATROPHY AND AMYOTROPHIC LATERAL SCLEROSIS
37. Autosomal Recessive Spastic Ataxia of Charlovoix-Saguenay. A new pathogenic mutation. (P1.8-014)
38. Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy
39. Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder
40. Caroline M. Klein, MD, PhD (1960–2017)
41. Tongue abnormalities on Brain MRI in patients with neuromuscular disorders (P2.128)
42. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine
43. Focal and Patchy Perifasicular Involvement Differentiates the Anti-Jo1 Inflammatory Myopathy (IM) from Dermatomyositis (DM) (P3.125)
44. Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine
45. Mutations in MEGF10 in a patient presenting with late onset myopathy and respiratory distress. (P2.041)
46. Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease
47. 60 - Neuromuscular Diseases and the Heart
48. CNS Toxoplasmosis: A Serious Complication Of Immunotherapy In The Neuromuscular Patient (P6.102)
49. HIV lumbosacral radiculoplexus neuropathy mimicking lymphoma: Diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve?
50. Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.